Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19

Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19

Current standard treatment of COVID-19 lacks in effective antiviral options. Plitidepsin, a cyclic depsipeptide authorized in Australia for patients with refractory multiple myeloma, has recently emerged as a candidate anti-SARS-CoV-2 agent. The aim of this review was to summarize current knowledge...

Full description

Bibliographic Details
Main Authors: Michail Papapanou, Eleni Papoutsi, Timoleon Giannakas, Paraskevi Katsaounou
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Journal of Personalized Medicine
Subjects:
plitidepsin
aplidin
COVID-19
SARS-CoV-2
antiviral agents
Online Access:https://www.mdpi.com/2075-4426/11/7/668

Similar Items

Similar Items